Furthermore, miRNAs and TFs targeting CD14, CYBB, NOD2, and TLR1 were predicted and a total of 20 differentially expressed miRNAs were identified in patients with osteonecrosis and controls. This evidence concerns the gene CYBB and osteonecrosis.